Drug recall · January 25, 2023
Rasagiline Mesylate Tablets 1 mg recall
Why: Presence of Foreign Substance- A complaint was received of black spots/shiny metallic speck on the tablets.
Class II: could cause temporary or reversible health problems; serious harm is remote.
The recall
- Product
Rasagiline Mesylate Tablets 1 mg; 30 tablets in HDPE bottle; Rx only; NDC 67877-260-30; Manufactured by Alkem Laboratories Ltd., India; Distributed by: Ascend Laboratories, LLC, Parsippany, NJ 07054
- Lots / codes
Lot # 22140903. Exp. Dec. 2024
- Quantity
- 12192 bottles
- Company
- Ascend Laboratories, LLC, Parsippany, NJ
- Distribution
- Customers in 19 states: CA, FL, GA, IL, KY, LA, MI, MN, MS, NC, NJ, NY, OH, PA, RI, TN, TX, WA, WI; Puerto Rico
- Initiated
- December 28, 2022 · Voluntary: Firm initiated
- Classified
- January 16, 2023
- Reported
- January 25, 2023
- Ended
- August 15, 2024
- How notified
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Rasagiline
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.